InformTx Therapeutic Drug Monitoring for IBD Patients Launched by Miraca Life Sciences

InformTx Therapeutic Drug Monitoring for IBD Patients Launched by Miraca Life Sciences
MiracalogoMiraca Life Sciences, an independent anatomic pathology lab based in Irving, Texas, is expanding into clinical pathology testing for patients with inflammatory bowel disease (IBD). Miraca's new InformTx therapeutic drug monitoring (TDM) service is Theradiaglogobased on technology and raw materials licensed from the French firm Theradiag, which has been offering TDM assays in Europe for years under the name LISA TRACKER. InformTXlogoInformTx testing assesses drug and anti-drug antibody blood levels for the biologic drugs infliximab (Remicade), adalimumab (Humira), certolizumab (Cimzia), and vedolizumab (Entyvio), mainly addressing IBDs such as Crohn's disease and u
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *